Crossmark

The Role of Serum Symmetric Dimethylarginine (SDMA) As Endogenous Biomarker of Renal Impairment in Correlation with Severity and Different Stages of Diabetic Kidney Disease

Crossref DOI link: https://doi.org/10.1186/s43162-025-00559-x

Published Online: 2025-10-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Omran, Dalia Roushdy Abdel Rahman

Mohamed, Nourhan Ashraf Kamal

Ramzy, Tarek Ramzy Abdelazim

Ramiz, Shady A.
License Information

Text and Data Mining valid from 2025-10-27

Version of Record valid from 2025-10-27
More Information

Article History

Received: 4 August 2025

Accepted: 19 October 2025

First Online: 27 October 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below